| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/11/2012 | CN102309597A Traditional Chinese medicine decoction for treating intractable headache |
| 01/11/2012 | CN102309594A Traditional Chinese medicine prescription for treating heart palpitations |
| 01/11/2012 | CN102309585A Chinese medicinal preparation for treating gastrosis |
| 01/11/2012 | CN102309577A Method for extracting total alkaloid from uncaria by utilization of supercritical CO2 |
| 01/11/2012 | CN102309576A Preparation method of uncaria total alkaloids |
| 01/11/2012 | CN102309575A Application of medicinal composition in preparing medicament for treating diabetic complication |
| 01/11/2012 | CN102309572A Blood nourishing oral liquid and preparation method thereof |
| 01/11/2012 | CN102309565A Traditional Chinese medicine composition for improving sleep and preparation method thereof |
| 01/11/2012 | CN102309549A Traditional Chinese medicine for preventing and treating hyperpyretic summer humidity disease |
| 01/11/2012 | CN102309533A Preparation method of total flavones of artemisia anomalas |
| 01/11/2012 | CN102309531A Detection method of American ginseng fingerprint |
| 01/11/2012 | CN102309528A Preparation method of active substance capable of resisting neurodegenerative disease |
| 01/11/2012 | CN102309515A Application of drug composition in preparation of drugs for treating insomnia |
| 01/11/2012 | CN102309511A Application of drug composition in preparation of drugs for treating insomnia |
| 01/11/2012 | CN102309509A Application of drug composition in preparation of analgesic drugs |
| 01/11/2012 | CN102309497A Pharmaceutical composition for cardio cerebrovascular diseases |
| 01/11/2012 | CN102309496A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases |
| 01/11/2012 | CN102309494A Medicinal application of pristimerin as inflammatory cytokine inhibitor |
| 01/11/2012 | CN102309471A Application of magnolol or derivative thereof to preparation of antiepileptic medicaments |
| 01/11/2012 | CN102309466A Oral quetiapine sustained-release tablet |
| 01/11/2012 | CN102309465A Sustained release tablet containing donepezil hydrochloride active component as well as preparation method and application thereof |
| 01/11/2012 | CN102309438A Midazolam medicament composition as well as preparation method and application thereof |
| 01/11/2012 | CN102100745B Oral administration medicament for treating depression |
| 01/11/2012 | CN102058753B Medicament for replenishing qi to invigorate spleen and preparation method |
| 01/11/2012 | CN102050774B Oxiracetam compound and new method thereof |
| 01/11/2012 | CN102008644B Drug for treating neurasthenia and application thereof |
| 01/11/2012 | CN102008643B Mixture for treating panasthenia |
| 01/11/2012 | CN101991765B Paste capable of tranquilizing mind and helping sleep |
| 01/11/2012 | CN101919926B Traditional Chinese medicine for treating migraine and preparation method thereof |
| 01/11/2012 | CN101919833B Application of aromatic compounds in preparing Caspase 3 inhibitor |
| 01/11/2012 | CN101914502B I-type canine adenovirus attenuated vaccine strain and application thereof |
| 01/11/2012 | CN101780103B Medicine compound of mecobalamin and light magnesium oxide and preparation method thereof |
| 01/11/2012 | CN101703752B Medicinal composition spray or aerosol for treating whitevein and preparation method thereof |
| 01/11/2012 | CN101647997B Influenza wind-dispelling capsule and preparation method and quality control method thereof |
| 01/11/2012 | CN101642504B Capsule for reinforcing yin and clearing deficient heat |
| 01/11/2012 | CN101632509B Medicinal treatment shoe |
| 01/11/2012 | CN101606915B Novel pharmaceutical formulations of modafinil |
| 01/11/2012 | CN101600698B Quinazolinone and isoquinolinone acetamide derivatives |
| 01/11/2012 | CN101570539B Morphinone quaternary ammonium salt derivatives and preparation method thereof |
| 01/11/2012 | CN101564495B Series medicaments for psychosis negative four-step therapy |
| 01/11/2012 | CN101528226B Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 01/11/2012 | CN101491650B Refined Yinqiao detoxification preparation and preparation method thereof |
| 01/11/2012 | CN101397327B Use of dihydro ginsenoside Rg2 |
| 01/11/2012 | CN101312725B Hexahydro cyclooctyl pyrazole cannabinoid modulators |
| 01/11/2012 | CN101305009B 氮杂取代的螺环衍生物 Aza-substituted spiro derivatives of |
| 01/11/2012 | CN101228155B Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 01/11/2012 | CN101209976B Substituted tartaric acid derivatives and use thereof for preparing beta-secretase inhibitor |
| 01/11/2012 | CN101045083B Dizziness-clearing soft capsule, its preparing method and detection method |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8093276 Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production |
| 01/10/2012 | US8093263 Substituted pyrazolo [1,5-a] pyrimidines as metabotropic glutamate antagonists |
| 01/10/2012 | US8093262 Use of huperzine for disorders |
| 01/10/2012 | US8093256 Use of 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 01/10/2012 | US8093237 Dibenzo[b,f][1,4]oxazapine compounds |
| 01/10/2012 | US8093042 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 01/10/2012 | US8092840 Dietary supplement and a method to enhance sleep and lucid dreaming |
| 01/10/2012 | CA2623982C Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists |
| 01/10/2012 | CA2508042C Pyridine/pyrazine-2-carboxamide derivatives and uses thereof |
| 01/10/2012 | CA2503719C Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 01/10/2012 | CA2498152C Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 01/10/2012 | CA2496756C Pyrrolidone derivatives as maob inhibitors |
| 01/10/2012 | CA2486553C Ibuprofen suspension |
| 01/10/2012 | CA2486183C Protein kinase inhibitors |
| 01/10/2012 | CA2483855C Methods for increasing the therapeutic response to electroconvulsive therapy ("ect") |
| 01/10/2012 | CA2479666C (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 01/10/2012 | CA2440605C Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 01/10/2012 | CA2427261C Aged companion pet diet |
| 01/10/2012 | CA2382105C Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 01/08/2012 | CA2745289A1 Films for delivery of a therapeutic agent |
| 01/07/2012 | CA2745341A1 Means and methods for activating vagus nerve |
| 01/05/2012 | WO2012003452A2 Perlecan domain v protects, repairs and restores ischemic brain stroke injury and motor function |
| 01/05/2012 | WO2012003418A2 Functionally selective ligands of dopamine d2 receptors |
| 01/05/2012 | WO2012002840A1 Pharmaceutical composition for treating central and peripheral nervous system diseases of vascular, traumatic, toxic, hypoxic and autoimmune origin |
| 01/05/2012 | WO2012002688A2 Methods of treating restless legs syndrome |
| 01/05/2012 | WO2012002687A2 Methods for treating bipolar disorder |
| 01/05/2012 | WO2012002680A2 2-pyridyl substituted imidazoles as therapeutic alk5 and/or alk4 inhibitors |
| 01/05/2012 | WO2012002583A1 Method for treating schizophrenia and related diseases with a combination therapy |
| 01/05/2012 | WO2012002522A1 Therapeutic agent for indications for haloperidol, and beverage or food |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012001525A2 Intelligent gate drive |
| 01/05/2012 | WO2012001438A1 Use of kynurenic acid amide derivatives for the treatment of huntington's disease |
| 01/05/2012 | WO2012001336A1 Treatment of cognitive disorders |
| 01/05/2012 | WO2012001308A1 Method for synthesizing ergoline alkaloids from indolic bicyclic compounds by double cyclization, resulting materials, and intermediate materials |
| 01/05/2012 | WO2012001201A1 Ingredient reconstituted from dry fruit and/or carob |
| 01/05/2012 | WO2012000933A1 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatement of alzheimer's disease and other forms of dementia |
| 01/05/2012 | WO2012000519A1 Aryl- and heteroarylamid derivatives as pde10a enzyme inhibitor |
| 01/05/2012 | WO2012000306A1 Phenyl nitrone compounds containing stilbene segment and use thereof |
| 01/05/2012 | WO2011143360A8 Compositions, methods and systems for the synthesis and use of imaging agents |
| 01/05/2012 | WO2011141824A3 Methods for identifying nmda receptor modulators |
| 01/05/2012 | WO2011130194A3 Methods for producing viloxazine salts and novel polymorphs thereof |
| 01/05/2012 | WO2011112428A3 Arylvinylazacycloalkane compounds for constipation |
| 01/05/2012 | WO2011109743A3 Synergistic effects of combinations of buprenorphine and opioids for the treatment of pain |
| 01/05/2012 | WO2011107870A3 Compounds and compositions and their use in the treatment of diseases related to copper retention |
| 01/05/2012 | WO2011094545A3 Compositions and methods for enhancing proteasome activity |
| 01/05/2012 | WO2011090317A3 Imidazopyrazinone derivatives with apoptosis inducing activity on cells |
| 01/05/2012 | WO2010139180A8 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 01/05/2012 | WO2010134846A8 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same |
| 01/05/2012 | WO2010133377A8 Fat blends and uses thereof |
| 01/05/2012 | US20120004318 Modified release formulations of memantine oral dosage forms |